Graham Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $746K | Buy |
43,091
+14,955
| +53% | +$259K | 0.01% | 639 |
|
|
2025
Q1 | $615K | Buy |
+28,136
| New | +$615K | 0.01% | 695 |
|
|
2024
Q4 | – | Sell |
-16,873
| Closed | -$487K | – | 1191 |
|
|
2024
Q3 | $487K | Buy |
16,873
+11,636
| +222% | +$336K | 0.01% | 613 |
|
|
2024
Q2 | $201K | Sell |
5,237
-1,505
| -22% | -$57.7K | ﹤0.01% | 840 |
|
|
2024
Q1 | $396K | Buy |
+6,742
| New | +$396K | 0.01% | 665 |
|
|
2022
Q3 | – | Sell |
-40,720
| Closed | -$1.84M | – | 1044 |
|
|
2022
Q2 | $1.84M | Buy |
40,720
+5,690
| +16% | +$257K | 0.07% | 222 |
|
|
2022
Q1 | $1.78M | Buy |
+35,030
| New | +$1.78M | 0.06% | 145 |
|